96 Wells 48 Wells High Precision and Specificity Human Kim 1 ELISA Kit
Cat.No E1099Hu
Storage: Store the reagents at 2-8°C. For over 6-month storage refer to the expiration date keep it at -20°C. Avoid repeated thaw cycles. If individual reagents are opened it is recommended that the kit be used within 1 month.
*This product is for research use only, not for use in diagnosis procedures. It’s highly recommend to read this instruction entirely before use.
Assay Principle
This kit is an Enzyme-Linked Immunosorbent Assay (ELISA). The plate has been pre-coated with human Kim-1 antibody. Kim-1 present in the sample is added and binds to antibodies coated on the wells. And then biotinylated human Kim-1 Antibody is added and binds to Kim-1 in the sample. Then Streptavidin-HRP is added and binds to the Biotinylated Kim-1 antibody. After incubation unbound Streptavidin-HRP is washed away during a washing step. Substrate solution is then added and color develops in proportion to the amount of human Kim-1. The reaction is terminated by addition of acidic stop solution and absorbance is measured at 450 nm.
Reagent Provided
Components | Quantity |
Standard Solution (12.8ng/ml) | 0.5ml x1 |
Pre-coated ELISA Plate | 12 * 8 well strips x1 |
Standard Diluent | 3ml x1 |
Streptavidin-HRP | 6ml x1 |
Stop Solution | 6ml x1 |
Substrate Solution A | 6ml x1 |
Substrate Solution B | 6ml x1 |
Wash Buffer Concentrate (30x) | 20ml x1 |
Biotinylated human Kim-1 Antibody | 1ml x1 |
User Instruction | 1 |
Plate Sealer | 2 pics |
Zipper bag | 1 pic |
Material Required But Not Supplied
Precision
Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision.
CV(%) = SD/mean x 100
Intra-Assay: CV<8%
Inter-Assay: CV<10%
Precautions
Reagent Preparation
All reagents should be brought to room temperature before use.
Standard Reconstitute the 120μl of the standard (12.8ng/ml) with 120μl of standard diluent to generate a 6.4ng/ml standard stock solution. Allow the standard to sit for 15 mins with gentle agitation prior to making dilutions. Prepare duplicate standard points by serially diluting the standard stock solution (6.4ng/ml) 1:2 with standard diluent to produce 3.2ng/ml, 1.6ng/ml, 0.8ng/ml and 0.4ng/ml solutions. Standard diluent serves as the zero standard(0 ng/ml). Any remaining solution should be frozen at -20°C and used within one month. Dilution of standard solutions suggested are as follows:
6.4ng/ml | Standard No.5 | 120μl Original Standard + 120μl Standard Diluent |
3.2ng/ml | Standard No.4 | 120μl Standard No.5 + 120μl Standard Diluent |
1.6ng/ml | Standard No.3 | 120μl Standard No.4 + 120μl Standard Diluent |
0.8ng/ml | Standard No.2 | 120μl Standard No.3 + 120μl Standard Diluent |
0.4ng/ml | Standard No.1 | 120μl Standard No.2 + 120μl Standard Diluent |
Standard Concentration | Standard No.5 | Standard No.4 | Standard No.3 | Standard No.2 | Standard No.1 |
12.8ng/ml | 6.4ng/ml | 3.2ng/ml | 1.6ng/ml | 0.8ng/ml | 0.4ng/ml |
Wash Buffer Dilute 20ml of Wash Buffer Concentrate 30x into deionized or distilled water to yield 500 ml of 1x Wash Buffer. If crystals have formed in the concentrate, mix gently until the crystals have completely dissolved.
Calculation of Result
Construct a standard curve by plotting the average OD for each standard on the vertical (Y) axis against the concentration on the horizontal (X) axis and draw a best fit curve through the points on the graph. These calculations can be best performed with computer-based curve-fitting software and the best fit line can be determined by regression analysis.
"Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes."
Siezen C.L., Bont L., Hodemaekers H.M., Ermers M.J., Doornbos G., Van't Slot R., Wijmenga C., Houwelingen H.C., Kimpen J.L., Kimman T.G., Hoebee B., Janssen R.
Pediatr. Infect. Dis. J. 28:333-335(2009)